ARID4B and nonpapillary renal cell carcinoma: While previous studies have reported that the transcript levels of BCAA catabolic enzymes are down-regulated in ccRCC (5, 28), the molecular mechanisms underlying this defective BCAA catabolism and its consequent role in RCC tumor progression were not studied.